Using a partial synthetic process, by extracting trabectedin or ET-743, a compound found in marine invertebrate., scientists are producing a natural cancer drug. They are isolating the genetic blueprint of the ET-743's producer by using advanced sequencing techniques. The insights will make it possible for scientists to culture the bacteria in the laboratory without its host.
The drug has been approved for use in patients in Europe and is in clinical trials in the US.
Subscribe to PharmaTutor News Alerts by Email >>
